Next-generation prognostic assessment for diffuse large B-cell lymphoma
- 1 September 2015
- journal article
- review article
- Published by Future Medicine Ltd in Future Oncology
- Vol. 11 (17), 2443-2457
- https://doi.org/10.2217/fon.15.144
Abstract
Current standard of care therapy for diffuse large B-cell lymphoma (DLBCL) cures a majority of patients with additional benefit in salvage therapy and autologous stem cell transplant for patients who relapse. The next generation of prognostic models for DLBCL aims to more accurately stratify patients for novel therapies and risk-adapted treatment strategies. This review discusses the significance of host genetic and tumor genomic alterations seen in DLBCL, clinical and epidemiologic factors, and how each can be integrated into risk stratification algorithms. In the future, treatment prediction and prognostic model development and subsequent validation will require data from a large number of DLBCL patients to establish sufficient statistical power to correctly predict outcome. Novel modeling approaches can augment these efforts.Keywords
This publication has 127 references indexed in Scilit:
- Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencingProceedings of the National Academy of Sciences of the United States of America, 2012
- CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) GroupThe Lancet Oncology, 2011
- Frequent mutation of histone-modifying genes in non-Hodgkin lymphomaNature, 2011
- Inactivating mutations of acetyltransferase genes in B-cell lymphomaNature, 2011
- B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell LymphomaThe American Journal of Surgical Pathology, 2010
- A genome-wide association study on African-ancestry populations for asthmaJournal of Allergy and Clinical Immunology, 2010
- Diffuse Large B-Cell LymphomaHematology/Oncology Clinics of North America, 2008
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysProceedings of the National Academy of Sciences of the United States of America, 2008
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1995